{"id":2070,"date":"2018-06-22T08:52:32","date_gmt":"2018-06-22T08:52:32","guid":{"rendered":"https:\/\/ga-ip.com\/?p=2070"},"modified":"2018-06-22T09:17:55","modified_gmt":"2018-06-22T09:17:55","slug":"barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity","status":"publish","type":"post","link":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/","title":{"rendered":"Barcelona patent court upholds valsartan-amlodipine patent invalidity"},"content":{"rendered":"

On 14 March 2018 the Barcelona Commercial Court Number 4 dismissed a patent infringement action brought by Novartis against the first generics in Spain of its valsartan and amlodipine medicinal product for the treatment of hypertension (Exforge). The court upheld the defendants’ counterclaim for invalidity of the asserted patent.<\/p>\n

 <\/p>\n

Read More<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

On 14 March 2018 the Barcelona Commercial Court Number 4 dismissed a patent infringement action brought by Novartis against the first generics in Spain of its valsartan and amlodipine medicinal product for the treatment of hypertension (Exforge). The court upheld the defendants’ counterclaim for invalidity of the asserted patent.<\/p>\n","protected":false},"author":1,"featured_media":2068,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-2070","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-11","description-off"],"yoast_head":"\nBarcelona patent court upholds valsartan-amlodipine patent invalidity - Grau & Angulo Abogados<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Barcelona patent court upholds valsartan-amlodipine patent invalidity - Grau & Angulo Abogados\" \/>\n<meta property=\"og:description\" content=\"On 14 March 2018 the Barcelona Commercial Court Number 4 dismissed a patent infringement action brought by Novartis against the first generics in Spain of its valsartan and amlodipine medicinal product for the treatment of hypertension (Exforge). The court upheld the defendants' counterclaim for invalidity of the asserted patent.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/\" \/>\n<meta property=\"og:site_name\" content=\"Grau & Angulo Abogados\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-22T08:52:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-06-22T09:17:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"713\" \/>\n\t<meta property=\"og:image:height\" content=\"425\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Grau & Angulo Abogados\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Grau & Angulo Abogados\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/\"},\"author\":{\"name\":\"Grau & Angulo Abogados\",\"@id\":\"https:\/\/ga-ip.com\/en\/#\/schema\/person\/bed27bd5e90dae5402366cb87d70749f\"},\"headline\":\"Barcelona patent court upholds valsartan-amlodipine patent invalidity\",\"datePublished\":\"2018-06-22T08:52:32+00:00\",\"dateModified\":\"2018-06-22T09:17:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/\"},\"wordCount\":56,\"publisher\":{\"@id\":\"https:\/\/ga-ip.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/\",\"url\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/\",\"name\":\"Barcelona patent court upholds valsartan-amlodipine patent invalidity - Grau & Angulo Abogados\",\"isPartOf\":{\"@id\":\"https:\/\/ga-ip.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg\",\"datePublished\":\"2018-06-22T08:52:32+00:00\",\"dateModified\":\"2018-06-22T09:17:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#primaryimage\",\"url\":\"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg\",\"contentUrl\":\"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg\",\"width\":713,\"height\":425},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/ga-ip.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Barcelona patent court upholds valsartan-amlodipine patent invalidity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ga-ip.com\/en\/#website\",\"url\":\"https:\/\/ga-ip.com\/en\/\",\"name\":\"Grau & Angulo Abogados\",\"description\":\"Grau & Angulo Abogados\",\"publisher\":{\"@id\":\"https:\/\/ga-ip.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ga-ip.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ga-ip.com\/en\/#organization\",\"name\":\"Grau & Angulo Abogados\",\"url\":\"https:\/\/ga-ip.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ga-ip.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ga-ip.com\/wp-content\/uploads\/2016\/08\/logo_retina_white.png\",\"contentUrl\":\"https:\/\/ga-ip.com\/wp-content\/uploads\/2016\/08\/logo_retina_white.png\",\"width\":500,\"height\":101,\"caption\":\"Grau & Angulo Abogados\"},\"image\":{\"@id\":\"https:\/\/ga-ip.com\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ga-ip.com\/en\/#\/schema\/person\/bed27bd5e90dae5402366cb87d70749f\",\"name\":\"Grau & Angulo Abogados\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/436e6362bf4be26ec4a8f64af42cdca28b7fb06ad098cfb87043aa1d6fe0d226?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/436e6362bf4be26ec4a8f64af42cdca28b7fb06ad098cfb87043aa1d6fe0d226?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/436e6362bf4be26ec4a8f64af42cdca28b7fb06ad098cfb87043aa1d6fe0d226?s=96&d=mm&r=g\",\"caption\":\"Grau & Angulo Abogados\"},\"url\":\"https:\/\/ga-ip.com\/en\/author\/admin_gba\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Barcelona patent court upholds valsartan-amlodipine patent invalidity - Grau & Angulo Abogados","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/","og_locale":"en_US","og_type":"article","og_title":"Barcelona patent court upholds valsartan-amlodipine patent invalidity - Grau & Angulo Abogados","og_description":"On 14 March 2018 the Barcelona Commercial Court Number 4 dismissed a patent infringement action brought by Novartis against the first generics in Spain of its valsartan and amlodipine medicinal product for the treatment of hypertension (Exforge). The court upheld the defendants' counterclaim for invalidity of the asserted patent.","og_url":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/","og_site_name":"Grau & Angulo Abogados","article_published_time":"2018-06-22T08:52:32+00:00","article_modified_time":"2018-06-22T09:17:55+00:00","og_image":[{"width":713,"height":425,"url":"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg","type":"image\/jpeg"}],"author":"Grau & Angulo Abogados","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Grau & Angulo Abogados"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#article","isPartOf":{"@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/"},"author":{"name":"Grau & Angulo Abogados","@id":"https:\/\/ga-ip.com\/en\/#\/schema\/person\/bed27bd5e90dae5402366cb87d70749f"},"headline":"Barcelona patent court upholds valsartan-amlodipine patent invalidity","datePublished":"2018-06-22T08:52:32+00:00","dateModified":"2018-06-22T09:17:55+00:00","mainEntityOfPage":{"@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/"},"wordCount":56,"publisher":{"@id":"https:\/\/ga-ip.com\/en\/#organization"},"image":{"@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#primaryimage"},"thumbnailUrl":"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/","url":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/","name":"Barcelona patent court upholds valsartan-amlodipine patent invalidity - Grau & Angulo Abogados","isPartOf":{"@id":"https:\/\/ga-ip.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#primaryimage"},"image":{"@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#primaryimage"},"thumbnailUrl":"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg","datePublished":"2018-06-22T08:52:32+00:00","dateModified":"2018-06-22T09:17:55+00:00","breadcrumb":{"@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#primaryimage","url":"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg","contentUrl":"https:\/\/ga-ip.com\/wp-content\/uploads\/2018\/06\/nuria.jpg","width":713,"height":425},{"@type":"BreadcrumbList","@id":"https:\/\/ga-ip.com\/en\/barcelona-patent-court-upholds-valsartanamlodipine-patent-invalidity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ga-ip.com\/en\/"},{"@type":"ListItem","position":2,"name":"Barcelona patent court upholds valsartan-amlodipine patent invalidity"}]},{"@type":"WebSite","@id":"https:\/\/ga-ip.com\/en\/#website","url":"https:\/\/ga-ip.com\/en\/","name":"Grau & Angulo Abogados","description":"Grau & Angulo Abogados","publisher":{"@id":"https:\/\/ga-ip.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ga-ip.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ga-ip.com\/en\/#organization","name":"Grau & Angulo Abogados","url":"https:\/\/ga-ip.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ga-ip.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ga-ip.com\/wp-content\/uploads\/2016\/08\/logo_retina_white.png","contentUrl":"https:\/\/ga-ip.com\/wp-content\/uploads\/2016\/08\/logo_retina_white.png","width":500,"height":101,"caption":"Grau & Angulo Abogados"},"image":{"@id":"https:\/\/ga-ip.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ga-ip.com\/en\/#\/schema\/person\/bed27bd5e90dae5402366cb87d70749f","name":"Grau & Angulo Abogados","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/436e6362bf4be26ec4a8f64af42cdca28b7fb06ad098cfb87043aa1d6fe0d226?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/436e6362bf4be26ec4a8f64af42cdca28b7fb06ad098cfb87043aa1d6fe0d226?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/436e6362bf4be26ec4a8f64af42cdca28b7fb06ad098cfb87043aa1d6fe0d226?s=96&d=mm&r=g","caption":"Grau & Angulo Abogados"},"url":"https:\/\/ga-ip.com\/en\/author\/admin_gba\/"}]}},"_links":{"self":[{"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/posts\/2070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/comments?post=2070"}],"version-history":[{"count":3,"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/posts\/2070\/revisions"}],"predecessor-version":[{"id":2075,"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/posts\/2070\/revisions\/2075"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/media\/2068"}],"wp:attachment":[{"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/media?parent=2070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/categories?post=2070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ga-ip.com\/en\/wp-json\/wp\/v2\/tags?post=2070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}